Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$7.67 -0.02 (-0.26%)
As of 08/4/2025 03:41 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$7.57
$7.67
50-Day Range
$6.25
$7.85
52-Week Range
$4.66
$7.99
Volume
717 shs
Average Volume
9,400 shs
Market Capitalization
$125.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Buy

Company Overview

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
BioHarvest enters fragrance industry with AI edge - ICYMI
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the beginning of 2025. Since then, BHST stock has increased by 24.1% and is now trading at $7.67.

BioHarvest Sciences Inc. (NASDAQ:BHST) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The business earned $7.64 million during the quarter, compared to analysts' expectations of $8.93 million. BioHarvest Sciences had a negative trailing twelve-month return on equity of 307.04% and a negative net margin of 31.30%.
Read the conference call transcript
.

Top institutional shareholders of BioHarvest Sciences include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
8/05/2025
Next Earnings (Confirmed)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
CIK
1723464
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+78.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.91 million
Net Margins
-31.30%
Pretax Margin
-31.13%
Return on Equity
-307.04%
Return on Assets
-33.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.51
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$27.70 million
Price / Sales
4.55
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
95.88

Miscellaneous

Outstanding Shares
16,425,000
Free Float
N/A
Market Cap
$125.98 million
Optionable
N/A
Beta
0.67
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners